• Amplifon agreed to sell its Indian business to Hearzap (Hearing Solutions Private Limited), exiting a unit that generated about EUR 12 million of revenue in 2025.
• The India operation includes about 115 company-owned clinics and 460 employees.
• The business had a negative impact on group EBITDA; the divestment is expected to lift the adjusted EBITDA margin under the Fit4Growth program.
• Closing is expected in the coming months, subject to customary closing conditions.
• No material non-recurring charges are expected from the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amplifon S.p.A. published the original content used to generate this news brief via via EMARKET SDIR/STORAGE, the storage and dissemination service for Italian listed companies operated by Teleborsa (Ref. ID: 0525-36-2026_TELEBORSA.pdf), on May 18, 2026, and is solely responsible for the information contained therein.